Screening Patients for Anxiety: Then What?
New recommendations from the US Preventive Services Task Force (USPSTF) gives busy primary physicians and their teams one more thing to implement and manage: anxiety screenings. While the recommendation that adults ages 64 and younger should be screened for anxiety is a major step toward improving mental health across the US, for many physicians, the question quickly becomes, ‘OK, screening will identify patients needing help; then what?’
Stephen Manlove, MD is one of the most entrepreneurial psychiatrists in the upper Midwest. Dr. Manlove graduated from the University of Minnesota Medical School and completed residencies in Psychiatry and Internal Medicine through the University of Virginia Medical School. He holds multiple board certifications in psychiatry/neurology, internal medicine and forensic psychiatry. This deep understanding of medicine gives him a unique ability to practice truly holistic psychiatry—fusing lifestyle changes and brain health best practices with genetic testing and a detailed laboratory workup to develop a personalized plan for each patient. As an early adopter of transcranial magnetic stimulation (TMS) and ketamine/Spravato, he and the Manlove Brain + Body team have helped thousands of patients suffering from treatment resistant depression, anxiety and PTSD.